Abstract |
Accumulating evidence indicates that aberrant regulation of metastasis-associated lung adenocarcinoma transcript 1 (MALAT-1), a long noncoding RNA ( lncRNA), plays a vital role in tumorigenesis. However, its association with breast cancer has not been systematically evaluated. In the current study, a meta-analysis was conducted to clarify the association between MALAT-1 and the prognosis and clinicopathological features of breast cancer. Relevant literature published in several databases was searched. Hazard ratio (HR) and odds ratio (OR) with 95% confidence interval (CI) were calculated to evaluate the effect of MALAT-1 expression on the survival outcomes and clinicopathological features of breast cancer. A total of 12 studies involving 4106 patients were identified. Pooled HR demonstrated that elevated MALAT-1 expression significantly predicted unfavorable overall survival (HR = 2.06, 95% CI: 1.66-2.56, P<0.0001) in patients with breast cancer. Subgroup analysis stratified by cancer type, sample size, and method of variance analysis also showed statistically significant associations. Additionally, the HR of patients with up-regulated MALAT-1 expression concerning disease-free survival (DFS), recurrence-free survival (RFS), and disease-specific survival (DSS) was 1.91 (95% CI: 1.53-2.39, P<0.0001). Further, elevated MALAT-1 expression was positively correlated with the progesterone receptor (PR) status (OR = 1.47, 95% CI: 1.18-1.82). Thus, MALAT-1 is a promising biomarker for predicting survival outcomes in patients with breast cancer.
|
Authors | Yanyan Wang, Yujie Zhang, Kaimin Hu, Jili Qiu, Yue Hu, Meiqi Zhou, Suzhan Zhang |
Journal | Bioscience reports
(Biosci Rep)
Vol. 40
Issue 8
(08 28 2020)
ISSN: 1573-4935 [Electronic] England |
PMID | 32700729
(Publication Type: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review)
|
Copyright | © 2020 The Author(s). |
Chemical References |
- Biomarkers, Tumor
- MALAT1 long non-coding RNA, human
- RNA, Long Noncoding
|
Topics |
- Biomarkers, Tumor
(genetics)
- Breast Neoplasms
(genetics, mortality, pathology, therapy)
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Prognosis
- RNA, Long Noncoding
(genetics)
- Risk Assessment
- Risk Factors
- Up-Regulation
|